Skip to content

MS Spinal Mobilisation Study

Analysis of a Spinal Mobilisation Intervention in People With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05090709
Enrollment
20
Registered
2021-10-25
Start date
2018-10-01
Completion date
2019-04-01
Last updated
2024-01-05

For informational purposes only โ€” not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

multiple sclerosis, myometer, muscle stiffness, spinal mobilisations, body sway, fatigue

Brief summary

The objective of the study is to measure the effect of a spinal mobilisation intervention on para-spinal muscle tissue quality, functional balance measures, pain and fatigue in people with multiple sclerosis. The mobilisation intervention group will be compared to a general massage group to analyse the difference between the specificities of the intervention compared to general manual touch. Participants will be randomly allocated to a group condition for a between-subject, repeated measures study. The study hypothesises a decrease in lumbar stiffness, body sway, pain and fatigue post the intervention compared to the general massage group.

Detailed description

The long term management of multiple sclerosis (MS) symptoms may often involve manual therapeutics due to observed improvements in muscle stiffness, pain, fatigue and balance. Though these improvements are often anecdotal without objective measurement and without analysis of the manual therapeutic. This is partly due to the vast array of manual therapeutics available as well as the many possible influencing factors contributing to these symptoms. The objective of this study is to measure and analyse the cumulative effect of a spinal mobilisation intervention on muscle tissue quality, functional balance, pain and fatigue in people with MS. The intervention will be analysed at a specific rate, pressure and location and compared to a general manual touch session with no specificities on rate, pressure or location. Both therapy sessions will be 30 minutes long. The force of both therapy sessions will be recorded in real time by monitoring the vertical ground reaction force (GRF) profile using 2 Kistler force plates placed underneath the treatment plinth. A 0 force will be generated once each participant is lying supine and still on the plinth and recordings will be taken in 30 second samples during the treatment sessions. The summation of the vertical GRFs will be graphed and monitored to check consistency of the treatment force. The mobilisation intervention will be given at a rate of 0.37Hz (22 beats per minute) maintained by a metronome on silent within view of the therapist, the pressure will be maintained at a pressure grade of less than 1 (equal to a threshold of 80N), and maintained consistent physical contact on paraspinal region within L1-L5. The general massage will be applied on the mid-lower back, with no specificities or consistencies; physical contact, rate and force magnitude will not be kept constant. This will be tested on 20 participants with MS who are randomly allocated to a group condition for a between-subject, repeated measures study. Participants will be randomly allocated to either an intervention or general massage group for which they will attend 4 separate therapy sessions. During the 1st session, the participants will carry out tests for lumbar muscle response, measured stiffness, tone and elasticity (using MyotonPro), functional balance measures in a single-leg balance and sit-to-stand tests (using Kistler force plates), self-reported pain and self-reported fatigue for pre and post treatment sessions. During the subsequent 3 sessions, the participants will complete tests for the myometer, balance and pain post the treatment sessions, and the final fatigue test will be completed after their last session. Participants will therefore complete 5 set of tests for the myometer, balance and pain and the fatigue test is completed pre and post all therapy sessions due to the set-up of the questionnaire. Participants will complete an online questionnaire before their 1st to screen for eligibility criteria and collect anthropometric details and information on their MS condition. This will be analysed with the results into descriptive statistics and summarised into mean, range and dispersion values. All dependent variables measured for muscle tissue response, functional balance, pain and fatigue will be analysed in between-subject repeated measured ANOVA to determine differences between the 2 treatment groups and between the different treatment time points. Pearson correlations will be carried out on the myometer variables to compare the baseline values to the level of change after their final session due to previously found significant correlations. More participants were intended for recruitment in the study, a post-hoc power calculation revealed a power of 0.9 with an alpha level at 0.05 with a range of large effect sizes in the results.

Interventions

OTHERSpinal Mobilisation Intervention

30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5.

OTHERGeneral Massage

30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch.

Sponsors

Scottish Hospital Endowments Research Trust
CollaboratorOTHER
Pacla Medical Limited
CollaboratorINDUSTRY
Edinburgh Napier University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Mixed factor: between-subject, repeated measures (mobilisation intervention vs general massage).

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Must have Multiple Sclerosis diagnosis. * Must be able to walk independently. * Must have an EDSS score of 6 or below.

Exclusion criteria

Respond positively to any absolute contraindications for spinal manual therapy including: * segment instability * infectious disease * osteomyelitis * bone tumours * severe haemophilia * spinal cord damage * cervical arterial dysfunction Respond positively to any relative contraindications for spinal manual therapy including: * spinal disc prolapse * spondylosis * inflammatory arthritides * osteoporosis * hypermobile syndrome * pregnancy * pregnancy * cancer * cardiovascular disease * respiratory disease * healing injury * adverse reaction to previous spinal treatment.

Design outcomes

Primary

MeasureTime frameDescription
Participant Muscle Stiffness MeasureTaken at baseline, pre-treatment.Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments.
Participant Single Leg Stance Body Sway Path LengthTaken at baseline, pre-treatment.Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document.
Participant Sit-to-Stand VelocityTaken at baseline, pre-treatment.Force plate recording from sit-to-stand test.
Participant Pain Score - Visual Analogue Scale (VAS)Taken at baseline, pre-treatment.Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.Taken at baseline, pre-treatment.Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.

Secondary

MeasureTime frameDescription
Participant Sit-to-Stand Rising IndexTaken at baseline, pre-treatment.Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document.
Participant Muscle Tone MeasureTaken at baseline, pre-treatment.Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments.
Participant Sit-to-Stand Weight TransferTaken at baseline, pre-treatment.Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document.
Participant Muscle Elasticity MeasureTaken at baseline, pre-treatment.Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments.
Participant Single Leg Stance Body Sway Anterior-Posterior Path LengthTaken at baseline, pre-treatment.Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document.
Participant Single Leg Stance Body Sway Medial-Lateral Path LengthTaken at baseline, pre-treatment.Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document.
Participant Single Leg Stance Body Sway VelocityTaken at baseline, pre-treatment.Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Experimental A - Mobilisation Intervention
Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention. Spinal Mobilisation Intervention: 30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5.
10
Experimental B - General Massage
Participants receive 4 separate treatment sessions of the 30 minute general massage. General Massage: 30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch.
10
Total20

Baseline characteristics

CharacteristicExperimental B - General MassageTotalExperimental A - Mobilisation Intervention
Age, Continuous39.4 years
STANDARD_DEVIATION 8.33
42.1 years
STANDARD_DEVIATION 10.81
44.8 years
STANDARD_DEVIATION 12.69
Body Mass Index26.95 Kilograms/meters^2
STANDARD_DEVIATION 7.29
26.95 Kilograms/meters^2
STANDARD_DEVIATION 7.61
26.95 Kilograms/meters^2
STANDARD_DEVIATION 8.48
Expanded Disability Status Scale2.15 Units on a scale
STANDARD_DEVIATION 0.75
2.3 Units on a scale
STANDARD_DEVIATION 0.8
2.45 Units on a scale
STANDARD_DEVIATION 0.86
Height (m)1.72 meters
STANDARD_DEVIATION 0.1
1.72 meters
STANDARD_DEVIATION 0.09
1.71 meters
STANDARD_DEVIATION 0.09
Mass (kg)81.15 Kilograms
STANDARD_DEVIATION 26.57
80.58 Kilograms
STANDARD_DEVIATION 27.53
80.01 Kilograms
STANDARD_DEVIATION 29.89
Race and Ethnicity Not Collectedโ€”0 Participantsโ€”
Sex: Female, Male
Female
7 Participants12 Participants5 Participants
Sex: Female, Male
Male
3 Participants8 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.

Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Fatigue Score - 5 Item Modified Fatigue Impact Scale.10.1 Units on a scaleStandard Error 1.22
Experimental B - General MassageParticipant Fatigue Score - 5 Item Modified Fatigue Impact Scale.8.7 Units on a scaleStandard Error 1.56
Primary

Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.

Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Fatigue Score - 5 Item Modified Fatigue Impact Scale.6.6 Units on a scaleStandard Error 0.92
Experimental B - General MassageParticipant Fatigue Score - 5 Item Modified Fatigue Impact Scale.7.4 Units on a scaleStandard Error 1.83
p-value: <0.05ANOVA
p-value: >0.05ANOVA
Primary

Participant Muscle Stiffness Measure

Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Stiffness Measure306.27 Newton-metresStandard Error 27.41
Experimental B - General MassageParticipant Muscle Stiffness Measure234.77 Newton-metresStandard Error 22.08
Primary

Participant Muscle Stiffness Measure

Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Stiffness Measure306.47 Newton-metresStandard Error 39.87
Experimental B - General MassageParticipant Muscle Stiffness Measure232.37 Newton-metresStandard Error 24.08
Primary

Participant Muscle Stiffness Measure

Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Stiffness Measure340.87 Newton-metresStandard Error 51.27
Experimental B - General MassageParticipant Muscle Stiffness Measure235.33 Newton-metresStandard Error 27.54
Primary

Participant Muscle Stiffness Measure

Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Stiffness Measure350.83 Newton-metresStandard Error 51.54
Experimental B - General MassageParticipant Muscle Stiffness Measure240.07 Newton-metresStandard Error 18.51
Primary

Participant Muscle Stiffness Measure

Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Stiffness Measure324.37 Newton-metresStandard Error 46.21
Experimental B - General MassageParticipant Muscle Stiffness Measure220.27 Newton-metresStandard Error 17.4
Comparison: Stiffness values were analysed as a percentage change from baseline measurements to normalise group variances.p-value: >0.05ANOVA
Comparison: Stiffness values were analysed as a percentage change from baseline measurements to normalise group variances.p-value: >0.05ANOVA
Primary

Participant Pain Score - Visual Analogue Scale (VAS)

Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Pain Score - Visual Analogue Scale (VAS)0.6 Units on a scaleStandard Error 0.34
Experimental B - General MassageParticipant Pain Score - Visual Analogue Scale (VAS)0.67 Units on a scaleStandard Error 0.21
Primary

Participant Pain Score - Visual Analogue Scale (VAS)

Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Pain Score - Visual Analogue Scale (VAS)0.5 Units on a scaleStandard Error 0.31
Experimental B - General MassageParticipant Pain Score - Visual Analogue Scale (VAS)0.7 Units on a scaleStandard Error 0.6
Primary

Participant Pain Score - Visual Analogue Scale (VAS)

Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Pain Score - Visual Analogue Scale (VAS)1.2 Units on a scaleStandard Error 0.57
Experimental B - General MassageParticipant Pain Score - Visual Analogue Scale (VAS)0.8 Units on a scaleStandard Error 0.59
Primary

Participant Pain Score - Visual Analogue Scale (VAS)

Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Pain Score - Visual Analogue Scale (VAS)0.5 Units on a scaleStandard Error 0.31
Experimental B - General MassageParticipant Pain Score - Visual Analogue Scale (VAS)0.3 Units on a scaleStandard Error 0.21
p-value: >0.05ANOVA
p-value: >0.05ANOVA
Primary

Participant Pain Score - Visual Analogue Scale (VAS)

Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Pain Score - Visual Analogue Scale (VAS)0.6 Units on a scaleStandard Error 0.34
Experimental B - General MassageParticipant Pain Score - Visual Analogue Scale (VAS)0.4 Units on a scaleStandard Error 0.22
Primary

Participant Single Leg Stance Body Sway Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Path Length389.22 MillimetersStandard Error 55.6
Experimental B - General MassageParticipant Single Leg Stance Body Sway Path Length491.92 MillimetersStandard Error 58.75
p-value: <0.05ANOVA
p-value: <0.05ANOVA
Primary

Participant Single Leg Stance Body Sway Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Path Length495.22 MillimetersStandard Error 57.12
Experimental B - General MassageParticipant Single Leg Stance Body Sway Path Length619.57 MillimetersStandard Error 77.36
Primary

Participant Single Leg Stance Body Sway Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Path Length458.45 MillimetersStandard Error 51.23
Experimental B - General MassageParticipant Single Leg Stance Body Sway Path Length524.29 MillimetersStandard Error 65.21
Primary

Participant Single Leg Stance Body Sway Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Path Length387.23 MillimetersStandard Error 52.1
Experimental B - General MassageParticipant Single Leg Stance Body Sway Path Length543.4 MillimetersStandard Error 73.15
Primary

Participant Single Leg Stance Body Sway Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Path Length386.32 MillimetersStandard Error 40.55
Experimental B - General MassageParticipant Single Leg Stance Body Sway Path Length509.36 MillimetersStandard Error 51.12
Primary

Participant Sit-to-Stand Velocity

Force plate recording from sit-to-stand test.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Velocity160.66 Millimeters/secondStandard Error 11.95
Experimental B - General MassageParticipant Sit-to-Stand Velocity156.41 Millimeters/secondStandard Error 20.78
Primary

Participant Sit-to-Stand Velocity

Force plate recording from sit-to-stand test.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Velocity164.18 Millimeters/secondStandard Error 18.13
Experimental B - General MassageParticipant Sit-to-Stand Velocity145.06 Millimeters/secondStandard Error 13.76
Comparison: Sit-to-stand velocity values were analysed as a percentage change from baseline measurements to normalise group variances.p-value: >0.05ANOVA
Comparison: Sit-to-stand velocity values were analysed as a percentage change from baseline measurements to normalise group variances.p-value: >0.05ANOVA
Primary

Participant Sit-to-Stand Velocity

Force plate recording from sit-to-stand test.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Velocity166.07 Millimeters/secondStandard Error 19
Experimental B - General MassageParticipant Sit-to-Stand Velocity131 Millimeters/secondStandard Error 9.38
Primary

Participant Sit-to-Stand Velocity

Force plate recording from sit-to-stand test.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Velocity189.25 Millimeters/secondStandard Error 13.77
Experimental B - General MassageParticipant Sit-to-Stand Velocity158.36 Millimeters/secondStandard Error 14.61
Primary

Participant Sit-to-Stand Velocity

Force plate recording from sit-to-stand test.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Velocity176.01 Millimeters/secondStandard Error 12.95
Experimental B - General MassageParticipant Sit-to-Stand Velocity142.65 Millimeters/secondStandard Error 14.04
Secondary

Participant Muscle Elasticity Measure

Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Elasticity Measure1.43 Natural log of acceleration peak ratioStandard Error 0.12
Experimental B - General MassageParticipant Muscle Elasticity Measure1.36 Natural log of acceleration peak ratioStandard Error 0.13
p-value: >0.05ANOVA
p-value: >0.05ANOVA
Secondary

Participant Muscle Elasticity Measure

Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Elasticity Measure1.39 Natural log of acceleration peak ratioStandard Error 0.12
Experimental B - General MassageParticipant Muscle Elasticity Measure1.36 Natural log of acceleration peak ratioStandard Error 0.13
Secondary

Participant Muscle Elasticity Measure

Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Elasticity Measure1.34 Natural log of acceleration peak ratioStandard Error 0.12
Experimental B - General MassageParticipant Muscle Elasticity Measure1.36 Natural log of acceleration peak ratioStandard Error 0.13
Secondary

Participant Muscle Elasticity Measure

Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Elasticity Measure1.36 Natural log of acceleration peak ratioStandard Error 0.13
Experimental B - General MassageParticipant Muscle Elasticity Measure1.35 Natural log of acceleration peak ratioStandard Error 0.1
Secondary

Participant Muscle Elasticity Measure

Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Elasticity Measure1.51 Natural log of acceleration peak ratioStandard Error 0.12
Experimental B - General MassageParticipant Muscle Elasticity Measure1.37 Natural log of acceleration peak ratioStandard Error 0.14
Secondary

Participant Muscle Tone Measure

Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Tone Measure14.86 HertzStandard Error 1.1
Experimental B - General MassageParticipant Muscle Tone Measure12.32 HertzStandard Error 0.5
Comparison: Muscle tone values were analysed as a percentage change from baseline measurements to normalise group variances.p-value: >0.05ANOVA
Comparison: Muscle tone values were analysed as a percentage change from baseline measurements to normalise group variances.p-value: >0.05ANOVA
Secondary

Participant Muscle Tone Measure

Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Tone Measure15.87 HertzStandard Error 1.48
Experimental B - General MassageParticipant Muscle Tone Measure13.2 HertzStandard Error 0.59
Secondary

Participant Muscle Tone Measure

Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Tone Measure14.93 HertzStandard Error 0.84
Experimental B - General MassageParticipant Muscle Tone Measure13 HertzStandard Error 0.84
Secondary

Participant Muscle Tone Measure

Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Tone Measure14.7 HertzStandard Error 1.05
Experimental B - General MassageParticipant Muscle Tone Measure12.83 HertzStandard Error 0.92
Secondary

Participant Muscle Tone Measure

Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Muscle Tone Measure15.46 HertzStandard Error 1.17
Experimental B - General MassageParticipant Muscle Tone Measure12.78 HertzStandard Error 0.83
Secondary

Participant Single Leg Stance Body Sway Anterior-Posterior Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length272.43 MillimetersStandard Error 25.31
Experimental B - General MassageParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length357.17 MillimetersStandard Error 36.47
Secondary

Participant Single Leg Stance Body Sway Anterior-Posterior Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length343 MillimetersStandard Error 43.38
Experimental B - General MassageParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length439.46 MillimetersStandard Error 56.91
Secondary

Participant Single Leg Stance Body Sway Anterior-Posterior Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length295.49 MillimetersStandard Error 23.98
Experimental B - General MassageParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length381.02 MillimetersStandard Error 57.68
Secondary

Participant Single Leg Stance Body Sway Anterior-Posterior Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length260.85 MillimetersStandard Error 28.08
Experimental B - General MassageParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length376.86 MillimetersStandard Error 55.14
Secondary

Participant Single Leg Stance Body Sway Anterior-Posterior Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length279.76 MillimetersStandard Error 42.15
Experimental B - General MassageParticipant Single Leg Stance Body Sway Anterior-Posterior Path Length323.6 MillimetersStandard Error 37.3
p-value: >0.05ANOVA
p-value: >0.05ANOVA
Secondary

Participant Single Leg Stance Body Sway Medial-Lateral Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Medial-Lateral Path Length282.06 MillimetersStandard Error 54.48
Experimental B - General MassageParticipant Single Leg Stance Body Sway Medial-Lateral Path Length286.16 MillimetersStandard Error 41.95
Secondary

Participant Single Leg Stance Body Sway Medial-Lateral Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Medial-Lateral Path Length211.89 MillimetersStandard Error 35.94
Experimental B - General MassageParticipant Single Leg Stance Body Sway Medial-Lateral Path Length275.46 MillimetersStandard Error 45.11
Secondary

Participant Single Leg Stance Body Sway Medial-Lateral Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Medial-Lateral Path Length223.9 MillimetersStandard Error 43.11
Experimental B - General MassageParticipant Single Leg Stance Body Sway Medial-Lateral Path Length291.16 MillimetersStandard Error 51.78
Secondary

Participant Single Leg Stance Body Sway Medial-Lateral Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Medial-Lateral Path Length205.69 MillimetersStandard Error 37.69
Experimental B - General MassageParticipant Single Leg Stance Body Sway Medial-Lateral Path Length296.17 MillimetersStandard Error 47.77
p-value: <0.05ANOVA
p-value: >0.05ANOVA
Secondary

Participant Single Leg Stance Body Sway Medial-Lateral Path Length

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Medial-Lateral Path Length275.19 MillimetersStandard Error 41.87
Experimental B - General MassageParticipant Single Leg Stance Body Sway Medial-Lateral Path Length351.67 MillimetersStandard Error 56.61
Secondary

Participant Single Leg Stance Body Sway Velocity

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Velocity38.57 Millimeters/secondStandard Error 5.52
Experimental B - General MassageParticipant Single Leg Stance Body Sway Velocity48.77 Millimeters/secondStandard Error 5.81
p-value: >0.05ANOVA
p-value: <0.05ANOVA
Secondary

Participant Single Leg Stance Body Sway Velocity

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Velocity37 Millimeters/secondStandard Error 3.66
Experimental B - General MassageParticipant Single Leg Stance Body Sway Velocity50.54 Millimeters/secondStandard Error 5.07
Secondary

Participant Single Leg Stance Body Sway Velocity

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Velocity49.02 Millimeters/secondStandard Error 5.67
Experimental B - General MassageParticipant Single Leg Stance Body Sway Velocity61.5 Millimeters/secondStandard Error 7.66
Secondary

Participant Single Leg Stance Body Sway Velocity

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Velocity45.36 Millimeters/secondStandard Error 5.07
Experimental B - General MassageParticipant Single Leg Stance Body Sway Velocity51.96 Millimeters/secondStandard Error 6.48
Secondary

Participant Single Leg Stance Body Sway Velocity

Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Single Leg Stance Body Sway Velocity38.42 Millimeters/secondStandard Error 5.17
Experimental B - General MassageParticipant Single Leg Stance Body Sway Velocity53.83 Millimeters/secondStandard Error 7.25
Secondary

Participant Sit-to-Stand Rising Index

Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Rising Index59.31 Percentage of Body WeightStandard Error 4.99
Experimental B - General MassageParticipant Sit-to-Stand Rising Index60.92 Percentage of Body WeightStandard Error 3.28
Secondary

Participant Sit-to-Stand Rising Index

Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Rising Index57.23 Percentage of Body WeightStandard Error 4.04
Experimental B - General MassageParticipant Sit-to-Stand Rising Index58.99 Percentage of Body WeightStandard Error 2.78
Secondary

Participant Sit-to-Stand Rising Index

Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Rising Index53.57 Percentage of Body WeightStandard Error 4.89
Experimental B - General MassageParticipant Sit-to-Stand Rising Index56.98 Percentage of Body WeightStandard Error 2.82
Secondary

Participant Sit-to-Stand Rising Index

Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Rising Index57.22 Percentage of Body WeightStandard Error 3.12
Experimental B - General MassageParticipant Sit-to-Stand Rising Index59.33 Percentage of Body WeightStandard Error 3.46
Secondary

Participant Sit-to-Stand Rising Index

Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Rising Index59.06 Percentage of Body WeightStandard Error 2.28
Experimental B - General MassageParticipant Sit-to-Stand Rising Index61.53 Percentage of Body WeightStandard Error 1.8
p-value: >0.05ANOVA
p-value: >0.05ANOVA
Secondary

Participant Sit-to-Stand Weight Transfer

Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Weight Transfer2.69 SecondsStandard Error 0.32
Experimental B - General MassageParticipant Sit-to-Stand Weight Transfer2.62 SecondsStandard Error 0.2
Secondary

Participant Sit-to-Stand Weight Transfer

Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document.

Time frame: Taken at baseline, pre-treatment.

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Weight Transfer3.83 SecondsStandard Error 0.77
Experimental B - General MassageParticipant Sit-to-Stand Weight Transfer2.37 SecondsStandard Error 0.13
Secondary

Participant Sit-to-Stand Weight Transfer

Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 1st treatment, same day as baseline measures (week 1).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Weight Transfer2.4 SecondsStandard Error 0.33
Experimental B - General MassageParticipant Sit-to-Stand Weight Transfer2.08 SecondsStandard Error 0.13
Secondary

Participant Sit-to-Stand Weight Transfer

Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Weight Transfer2.83 SecondsStandard Error 0.36
Experimental B - General MassageParticipant Sit-to-Stand Weight Transfer2.11 SecondsStandard Error 0.23
Secondary

Participant Sit-to-Stand Weight Transfer

Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document.

Time frame: Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4).

ArmMeasureValue (MEAN)Dispersion
Experimental A - Mobilisation InterventionParticipant Sit-to-Stand Weight Transfer2.44 SecondsStandard Error 0.21
Experimental B - General MassageParticipant Sit-to-Stand Weight Transfer2 SecondsStandard Error 0.15
p-value: <0.05ANOVA
p-value: <0.05ANOVA

Source: ClinicalTrials.gov ยท Data processed: Feb 4, 2026